×
About 1,706 results

ALLMedicine™ Hypersensitivity Pneumonitis Center

Research & Reviews  835 results

Exposures and associations with clinical phenotypes in hypersensitivity pneumonitis: A ...
https://doi.org/10.1016/j.rmed.2021.106444
Respiratory Medicine; Barnes H, Lu J et. al.

May 15th, 2021 - Antigen identification is important for establishing a confident diagnosis of hypersensitivity pneumonitis (HP). There are no systematically curated lists of HP-associated exposures that inform clinical relevance or disease phenotype. We sought to...

IL-10 producing B cells regulated 1,3-β-glucan induced Th responses in coordinated with...
https://doi.org/10.1016/j.imlet.2021.04.011
Immunology Letters; Zhang Q, Lu Y et. al.

May 5th, 2021 - Repeated exposure to fungi-contaminated dust can lead to multiple adverse effects on the lung, such as hypersensitivity pneumonitis, granuloma even irreversible fibrosis. 1,3-β-glucan, a major cell wall component of fungi, is considered as its exp...

Performance of a diagnostic algorithm for fibrotic hypersensitivity pneumonitis. A case...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8063331
Respiratory Research; Guler SA, Wohlfarth E et. al.

Apr 24th, 2021 - The differential diagnosis fibrotic hypersensitivity pneumonitis (HP) versus idiopathic pulmonary fibrosis (IPF) is important but challenging. Recent diagnostic guidelines for HP emphasize including multidisciplinary discussion (MDD) in the diagno...

Executive Summary Diagnosis and Evaluation of Hypersensitivity Pneumonitis: CHEST Guide...
https://doi.org/10.1016/j.chest.2021.03.067
Chest Fernández Pérez ER, Travis WD et. al.

Apr 18th, 2021 - The purpose of this analysis is to provide evidence-based and consensus-derived guidance for clinicians to improve individual diagnostic decision-making for hypersensitivity pneumonitis (HP) and decrease diagnostic practice variability. Approved p...

Diagnosis and Evaluation of Hypersensitivity Pneumonitis: CHEST Guideline and Expert Pa...
https://doi.org/10.1016/j.chest.2021.03.066
Chest Fernández Pérez ER, Travis WD et. al.

Apr 16th, 2021 - The purpose of this analysis is to provide evidence-based and consensus-derived guidance for clinicians to improve individual diagnostic decision-making for hypersensitivity pneumonitis (HP) and decrease diagnostic practice variability. Approved p...

see more →

Guidelines  3 results

Executive Summary Diagnosis and Evaluation of Hypersensitivity Pneumonitis: CHEST Guide...
https://doi.org/10.1016/j.chest.2021.03.067
Chest Fernández Pérez ER, Travis WD et. al.

Apr 18th, 2021 - The purpose of this analysis is to provide evidence-based and consensus-derived guidance for clinicians to improve individual diagnostic decision-making for hypersensitivity pneumonitis (HP) and decrease diagnostic practice variability. Approved p...

Diagnosis and Evaluation of Hypersensitivity Pneumonitis: CHEST Guideline and Expert Pa...
https://doi.org/10.1016/j.chest.2021.03.066
Chest Fernández Pérez ER, Travis WD et. al.

Apr 16th, 2021 - The purpose of this analysis is to provide evidence-based and consensus-derived guidance for clinicians to improve individual diagnostic decision-making for hypersensitivity pneumonitis (HP) and decrease diagnostic practice variability. Approved p...

Diagnosis of Hypersensitivity Pneumonitis in Adults. An Official ATS/JRS/ALAT Clinical ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7397797
American Journal of Respiratory and Critical Care Medicine; Raghu G, Remy-Jardin M et. al.

Jul 24th, 2020 - Background: This guideline addresses the diagnosis of hypersensitivity pneumonitis (HP). It represents a collaborative effort among the American Thoracic Society, Japanese Respiratory Society, and Asociación Latinoamericana del Tórax.Methods: Syst...

see more →

Clinicaltrials.gov  849 results

Exposures and associations with clinical phenotypes in hypersensitivity pneumonitis: A ...
https://doi.org/10.1016/j.rmed.2021.106444
Respiratory Medicine; Barnes H, Lu J et. al.

May 15th, 2021 - Antigen identification is important for establishing a confident diagnosis of hypersensitivity pneumonitis (HP). There are no systematically curated lists of HP-associated exposures that inform clinical relevance or disease phenotype. We sought to...

IL-10 producing B cells regulated 1,3-β-glucan induced Th responses in coordinated with...
https://doi.org/10.1016/j.imlet.2021.04.011
Immunology Letters; Zhang Q, Lu Y et. al.

May 5th, 2021 - Repeated exposure to fungi-contaminated dust can lead to multiple adverse effects on the lung, such as hypersensitivity pneumonitis, granuloma even irreversible fibrosis. 1,3-β-glucan, a major cell wall component of fungi, is considered as its exp...

Performance of a diagnostic algorithm for fibrotic hypersensitivity pneumonitis. A case...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8063331
Respiratory Research; Guler SA, Wohlfarth E et. al.

Apr 24th, 2021 - The differential diagnosis fibrotic hypersensitivity pneumonitis (HP) versus idiopathic pulmonary fibrosis (IPF) is important but challenging. Recent diagnostic guidelines for HP emphasize including multidisciplinary discussion (MDD) in the diagno...

Executive Summary Diagnosis and Evaluation of Hypersensitivity Pneumonitis: CHEST Guide...
https://doi.org/10.1016/j.chest.2021.03.067
Chest Fernández Pérez ER, Travis WD et. al.

Apr 18th, 2021 - The purpose of this analysis is to provide evidence-based and consensus-derived guidance for clinicians to improve individual diagnostic decision-making for hypersensitivity pneumonitis (HP) and decrease diagnostic practice variability. Approved p...

Diagnosis and Evaluation of Hypersensitivity Pneumonitis: CHEST Guideline and Expert Pa...
https://doi.org/10.1016/j.chest.2021.03.066
Chest Fernández Pérez ER, Travis WD et. al.

Apr 16th, 2021 - The purpose of this analysis is to provide evidence-based and consensus-derived guidance for clinicians to improve individual diagnostic decision-making for hypersensitivity pneumonitis (HP) and decrease diagnostic practice variability. Approved p...

see more →

News  19 results

No Link Seen Between Methotrexate, Interstitial Lung Disease in RA
https://www.medscape.com/viewarticle/932183

Jun 10th, 2020 - Patients with RA have an elevated risk of interstitial lung disease (ILD), but methotrexate does not accentuate that risk and may in fact be protective, new data show. These were among key findings of a pair of studies reported at the annual Europ...

CT honeycombing key to hypersensitivity pneumonitis prognosis
https://www.mdedge.com/fedprac/article/198490/pulmonology/ct-honeycombing-key-hypersensitivity-pneumonitis-prognosis
Andrew D. Bowser

Apr 9th, 2019 - In patients with hypersensitivity pneumonitis, presence of radiologic honeycombing suggests a poor prognosis in line with what might be expected with idiopathic pulmonary fibrosis, results of a recent study suggest. When radiologic honeycombing wa.

CT scan honeycombing key to hypersensitivity pneumonitis prognosis
https://www.mdedge.com/internalmedicine/article/198490/pulmonology/ct-scan-honeycombing-key-hypersensitivity-pneumonitis?channel=39313
Andrew D. Bowser

Apr 9th, 2019 - In patients with hypersensitivity pneumonitis, presence of radiologic honeycombing suggests a poor prognosis in line with what might be expected with idiopathic pulmonary fibrosis, results of a recent study suggest. When radiologic honeycombing wa.

FDA recommends voluntary recall of Limbrel
https://www.mdedge.com/familymedicine/article/153691/osteoarthritis/fda-recommends-voluntary-recall-limbrel
Rheumatology News; Dan Watson

Dec 6th, 2017 - The Food and Drug Administration announced on Dec. 4 that it recommends the voluntary recall of Limbrel, a medical food product in capsule form that is currently marketed to “manage the metabolic processes associated with osteoarthritis.

The rise and fall of treatment trials in group 3 pulmonary hypertension: Where do we go from here?
https://www.mdedge.com/chestphysician/article/153652/pulmonology/rise-and-fall-treatment-trials-group-3-pulmonary/page/0/1

Dec 6th, 2017 - To be included in RISE-IIP, patients were required to have an idiopathic interstitial pneumonia, PH confirmed by RHC with a mPAP ≥ 25 mm Hg, World Health Organization Functional Class 2-4 symptoms, and a forced vital capacity (FVC) ≥ 45% predicted.

see more →